Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
14.13
-0.03 (-0.21%)
At close: Aug 1, 2025, 4:00 PM
14.41
+0.28 (1.98%)
After-hours: Aug 1, 2025, 6:20 PM EDT
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 1 or 3.33% compared to the previous year.
Employees
31
Change (1Y)
1
Growth (1Y)
3.33%
Revenue / Employee
$1,558,935
Profits / Employee
-$147,871
Market Cap
378.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | 1 | 3.33% |
| Dec 31, 2023 | 30 | 2 | 7.14% |
| Dec 31, 2022 | 28 | 11 | 64.71% |
| Dec 31, 2021 | 17 | 1 | 6.25% |
| Dec 31, 2020 | 16 | -1 | -5.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ETON News
- 5 days ago - Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - GlobeNewsWire
- 18 days ago - Eton Pharma Near Term Catalysts Vanish - Seeking Alpha
- 25 days ago - Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) - GlobeNewsWire
- 5 weeks ago - Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside - Seeking Alpha
- 2 months ago - FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue - Benzinga
- 2 months ago - Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Set To Dominate Orphan Drug Niche - Seeking Alpha